Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer

Clinical trial NCT05453799 · SUSPENDED

Trial details

NCT number: NCT05453799
Sponsor: Northwestern University
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Thyroid Gland Anaplastic Carcinoma Metastatic Thyroid Gland Anaplastic Carcinoma Metastatic Thyroid Gland Oncocytic Carcinoma

Start date: 2022-07-21
Primary completion: 2023-10-31
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.